S Aebi Selected Research

S Aebi Research Topics

Disease

12	Breast Neoplasms (Breast Cancer) 10/2021 - 05/2000
10	Neoplasms (Cancer) 10/2021 - 01/2000
5	Ovarian Neoplasms (Ovarian Cancer) 09/2005 - 10/2000
4	Adenocarcinoma 12/2015 - 01/2001
4	Pancreatic Neoplasms (Pancreatic Cancer) 04/2003 - 01/2001
2	Carcinoma (Carcinomatosis) 01/2018 - 09/2005
2	Disease Progression 01/2017 - 01/2001
2	Brain Neoplasms (Brain Tumor) 12/2015 - 09/2015
2	Adenoma (Adenomas) 09/2005 - 10/2000
2	Ovarian Epithelial Carcinoma 09/2005 - 10/2000
2	Pain (Aches) 01/2001 - 01/2000
1	Hemangiosarcoma (Angiosarcoma) 01/2018
1	Diarrhea 11/2017
1	Hand-Foot Syndrome 11/2017
1	Leukopenia 01/2017
1	Osteoporosis 06/2012
1	Endometrial Neoplasms (Endometrial Cancer) 06/2004
1	Osteoporotic Fractures 06/2004
1	Asthenia 01/2001
1	Thrombosis (Thrombus) 01/2001
1	Lymphoma (Lymphomas) 05/2000
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 05/2000
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 05/2000

Drug/Important Bio-Agent (IBA)

5	Fluorouracil (Carac)FDA LinkGeneric 11/2017 - 05/2000
5	Messenger RNA (mRNA)IBA 09/2005 - 01/2000
4	Tamoxifen FDA LinkGeneric 01/2018 - 06/2004
4	Proteins (Proteins, Gene)FDA Link 01/2017 - 05/2000
3	Letrozole (Femara)FDA LinkGeneric 10/2021 - 06/2004
3	Estrogen ReceptorsIBA 01/2018 - 01/2011
3	Gemcitabine FDA Link 04/2003 - 01/2001
2	Capecitabine (Xeloda)FDA Link 11/2017 - 12/2004
2	human ERBB2 proteinIBA 12/2015 - 09/2015
2	Methotrexate (Mexate)FDA LinkGeneric 09/2011 - 05/2000
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2011 - 05/2000
2	Biomarkers (Surrogate Marker)IBA 04/2007 - 05/2000
1	Hormones (Hormone)IBA 10/2021
1	Estrogens (Estrogen)FDA Link 10/2021
1	Androgen Receptors (Androgen Receptor)IBA 01/2018
1	NivolumabIBA 01/2018
1	Phenobarbital (Luminal)FDA Link 01/2018
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2018
1	Cytidine DeaminaseIBA 11/2017
1	ProdrugsIBA 11/2017
1	Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA 01/2017
1	EnzymesIBA 01/2017
1	Floxuridine (FUdR)FDA LinkGeneric 01/2017
1	Trastuzumab (Herceptin)FDA Link 01/2017
1	Formaldehyde (Formol)FDA Link 01/2011
1	ParaffinIBA 01/2011
1	Indicators and Reagents (Reagents)IBA 04/2007
1	Alkaline PhosphataseIBA 04/2007
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 09/2005
1	Therapeutic UsesIBA 09/2005
1	RetinoidsIBA 09/2005
1	Vinorelbine (Navelbine)FDA LinkGeneric 12/2004
1	Anastrozole (Arimidex)FDA LinkGeneric 06/2004
1	exemestane (Aromasin)FDA Link 06/2004
1	Aromatase InhibitorsIBA 06/2004
1	raltitrexed (D 1694)IBA 04/2003
1	bcl-X ProteinIBA 10/2001
1	Antisense OligonucleotidesIBA 10/2001
1	FluorodeoxyuridylateIBA 05/2001
1	ErbB Receptors (EGF Receptor)IBA 05/2001
1	Epidermal Growth Factor (EGF)IBA 05/2001
1	Cisplatin (Platino)FDA LinkGeneric 05/2001
1	DNA (Deoxyribonucleic Acid)IBA 05/2001
1	Analgesics (Analgesic Drugs)IBA 01/2001
1	Tumor Protein p73IBA 10/2000
1	Protein Isoforms (Isoforms)IBA 10/2000
1	Prednisone (Sone)FDA LinkGeneric 05/2000
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 05/2000
1	Tumor Suppressor Protein p14ARF (p14ARF)IBA 05/2000
1	Cyclin-Dependent Kinase Inhibitor p16IBA 05/2000
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2000
1	IceIBA 01/2000
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2000
1	morphine-3-glucuronideIBA 01/2000
1	Morphine (MS Contin)FDA LinkGeneric 01/2000

Therapy/Procedure

12	Drug Therapy (Chemotherapy) 01/2017 - 01/2000
10	Therapeutics 01/2018 - 10/2001
2	Adjuvant Chemotherapy 01/2018 - 09/2011
1	Adjuvant Radiotherapy 01/2018
1	Segmental Mastectomy (Lumpectomy) 01/2018
1	Hysterectomy 06/2012
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 06/2012
1	Catheters 01/2001
1	Ovariectomy (Oophorectomy) 05/2000